Fora Capital, LLC Moderna, Inc. Transaction History

Fora Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$118.38 - $210.04 $4.87 Million - $8.64 Million	41,140 New	41,140 $7.39 Million
Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $2.46 Million - $3.71 Million	-21,002 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $2.66 Million - $4.94 Million	21,002 New	21,002 $3.67 Million
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $1.81 Million - $2.95 Million	-8,007 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $1.78 Million - $3.88 Million	8,007 New	8,007 $3.08 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $1.39 Million - $2.51 Million	-10,699 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $3.1 Million - $5.28 Million	-28,376 Reduced 72.62%	10,699 $1.4 Billion
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $2.57 Million - $6.64 Million	39,075 New	39,075 $4.08 Million
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $1.41 Million - $3.8 Million	-47,533 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $845,136 - $1.5 Million	47,533 New	47,533 $1.42 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.